Wall Street Experts
ver. ZuMIgo(08/25)
Kyverna Therapeutics, Inc. Common Stock
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -110
| index |
0 |
1 |
2 |
3 |
| Rok finansowy |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
6 |
7 |
0 |
0 |
| Przychód Δ r/r |
0.0% |
24.2% |
-100.0% |
0.0% |
| Marża brutto |
89.6% |
85.0% |
-inf% |
0.0% |
| EBIT (mln) |
-26 |
-29 |
-62 |
-143 |
| EBIT Δ r/r |
0.0% |
11.5% |
112.4% |
128.5% |
| EBIT (%) |
-465.8% |
-418.3% |
0.0% |
nan |
| Koszty finansowe (mln) |
0 |
0 |
0 |
-0 |
| EBITDA (mln) |
-26 |
-28 |
-58 |
-143 |
| EBITDA(%) |
-455.5% |
-395.4% |
0.0% |
nan |
| Podatek (mln) |
0 |
0 |
0 |
0 |
| Zysk Netto (mln) |
-26 |
-29 |
-60 |
-127 |
| Zysk netto Δ r/r |
0.0% |
9.7% |
108.9% |
111.2% |
| Zysk netto (%) |
-465.9% |
-411.3% |
0.0% |
nan |
| EPS |
-1.02 |
-1.12 |
-0.0001 |
-3.33 |
| EPS (rozwodnione) |
-1.02 |
-1.12 |
-0.0001 |
-3.33 |
| Ilośc akcji (mln) |
26 |
26 |
674 |
38 |
| Ważona ilośc akcji (mln) |
26 |
26 |
674 |
38 |
| Waluta |
USD |
USD |
USD |
USD |